ASX - By Stock
|
IPD |
Re:
Ann: Notification of Quarterly Results & Investor, Revised
|
|
SBates
|
58 |
19K |
2 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
58
|
19K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notification of Quarterly Results & Investor, Revised
|
|
SBates
|
58 |
19K |
3 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
58
|
19K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SBates
|
153 |
45K |
19 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
153
|
45K
|
19
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SBates
|
153 |
45K |
3 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
153
|
45K
|
3
|
|
ASX - By Stock
|
DUB |
Re:
News: DUB Dubber Corp Announces Dismissal Of Managing Director & CEO Steve McGovern
|
|
SBates
|
179 |
117K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
179
|
117K
|
6
|
|
ASX - By Stock
|
DUB |
Re:
News: DUB Dubber Corp Announces Dismissal Of Managing Director & CEO Steve McGovern
|
|
SBates
|
179 |
117K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
179
|
117K
|
6
|
|
ASX - By Stock
|
DUB |
Re:
News: DUB Dubber Corp Announces Dismissal Of Managing Director & CEO Steve McGovern
|
|
SBates
|
179 |
117K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
179
|
117K
|
2
|
|
ASX - By Stock
|
DUB |
Re:
Dubber.Dubber.Do.
|
|
SBates
|
8.3K |
3.8M |
14 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
8.3K
|
3.8M
|
14
|
|
ASX - By Stock
|
DUB |
Re:
News: DUB Dubber Corp Announces Dismissal Of Managing Director & CEO Steve McGovern
|
|
SBates
|
179 |
117K |
8 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
179
|
117K
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
SBates
|
237 |
84K |
4 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
237
|
84K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SBates
|
153 |
45K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
153
|
45K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SBates
|
153 |
45K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
153
|
45K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: New Clinical Practice Guidance Recommends Use of BIS
|
|
SBates
|
65 |
12K |
5 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
65
|
12K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
SBates
|
280 |
61K |
4 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
280
|
61K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
SBates
|
280 |
61K |
0 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
280
|
61K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
SBates
|
280 |
61K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
280
|
61K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
SBates
|
280 |
61K |
6 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
280
|
61K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
SBates
|
280 |
61K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
280
|
61K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
SBates
|
280 |
61K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
280
|
61K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notification of Results Release Dates and Conference Call
|
|
SBates
|
31 |
7.8K |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
31
|
7.8K
|
6
|
|
ASX - By Stock
|
IPD |
Q2 predictions?
|
|
SBates
|
55 |
18K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
55
|
18K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
trading is changing .....
|
|
SBates
|
28 |
7.3K |
7 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
28
|
7.3K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Largest US Private Payor Updates Medical Policy for BIS
|
|
SBates
|
41 |
13K |
12 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
41
|
13K
|
12
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Largest US Private Payor Updates Medical Policy for BIS
|
|
SBates
|
41 |
13K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
41
|
13K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Sep-23 Qtr
|
|
SBates
|
89 |
23K |
4 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
89
|
23K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Change in substantial holding
|
|
SBates
|
11 |
4.0K |
3 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
11
|
4.0K
|
3
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
SBates
|
856 |
365K |
4 |
17/10/23 |
17/10/23 |
Charts
|
856
|
365K
|
4
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
SBates
|
856 |
365K |
9 |
13/10/23 |
13/10/23 |
Charts
|
856
|
365K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Initial Director's Interest Notice - Ms Janelle Delaney
|
|
SBates
|
22 |
5.3K |
5 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
22
|
5.3K
|
5
|
|
ASX - By Stock
|
IPD |
Petition to hear the New Directors plan
|
|
SBates
|
5 |
1.2K |
15 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
5
|
1.2K
|
15
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Market Update - Executing Towards Profitability in Oncology
|
|
SBates
|
117 |
30K |
3 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
117
|
30K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Market Update - Executing Towards Profitability in Oncology
|
|
SBates
|
117 |
30K |
7 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
117
|
30K
|
7
|
|
ASX - By Stock
|
IPD |
New broker research - 39c price target
|
|
SBates
|
0 |
610 |
25 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
0
|
610
|
25
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
SBates
|
856 |
365K |
9 |
20/07/23 |
20/07/23 |
Charts
|
856
|
365K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
100% not happy with the board
|
|
SBates
|
34 |
9.7K |
13 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
34
|
9.7K
|
13
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Mar-23 Qtr
|
|
SBates
|
141 |
41K |
8 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
141
|
41K
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Mar-23 Qtr
|
|
SBates
|
141 |
41K |
8 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
141
|
41K
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Mar-23 Qtr
|
|
SBates
|
141 |
41K |
2 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
141
|
41K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
how many people to get tested...
|
|
SBates
|
44 |
15K |
6 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
44
|
15K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: NCCN Guidelines Now Recommend Bioimpedance Spectroscopy
|
|
SBates
|
136 |
53K |
5 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
136
|
53K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Follow up to NCCN Guidelines for Breast Cancer ASX Release
|
|
SBates
|
70 |
25K |
3 |
26/03/23 |
26/03/23 |
ASX - By Stock
|
70
|
25K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C - Quarter ended 31 December 2020
|
|
SBates
|
20 |
7.4K |
4 |
30/01/21 |
30/01/21 |
ASX - By Stock
|
20
|
7.4K
|
4
|
|
ASX - By Stock
|
HHR |
farm-in partner talking up mazagan
|
|
SBates
|
1 |
857 |
13 |
03/07/13 |
03/07/13 |
ASX - By Stock
|
1
|
857
|
13
|
|
ASX - By Stock
|
HHR |
Re:
pvd's upside
|
|
SBates
|
12 |
862 |
0 |
03/06/13 |
03/06/13 |
ASX - By Stock
|
12
|
862
|
0
|
|
ASX - By Stock
|
HHR |
Re:
Ann: Placement to Raise $8 Million
|
|
SBates
|
14 |
1.0K |
6 |
01/05/13 |
01/05/13 |
ASX - By Stock
|
14
|
1.0K
|
6
|
|
ASX - By Stock
|
HHR |
Re:
Ann: Placement to Raise $8 Million
|
|
SBates
|
14 |
1.0K |
2 |
01/05/13 |
01/05/13 |
ASX - By Stock
|
14
|
1.0K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
shareholder tour april 9th
|
|
SBates
|
117 |
3.5K |
5 |
08/04/13 |
08/04/13 |
ASX - By Stock
|
117
|
3.5K
|
5
|
|
ASX - By Stock
|
FDM |
Re:
wow what a sell off
|
|
SBates
|
51 |
4.3K |
1 |
15/11/12 |
15/11/12 |
ASX - By Stock
|
51
|
4.3K
|
1
|
|
ASX - By Stock
|
FDM |
Re:
qtr ann oyt
|
|
SBates
|
42 |
4.7K |
3 |
03/11/12 |
03/11/12 |
ASX - By Stock
|
42
|
4.7K
|
3
|
|
ASX - By Stock
|
FDM |
Re:
qtr ann oyt
|
|
SBates
|
42 |
4.7K |
10 |
02/11/12 |
02/11/12 |
ASX - By Stock
|
42
|
4.7K
|
10
|
|